Tahlita C.M. Zuiverloon

Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome

Yves Allory, Willemien Beukers, Ana Sagrera et al. · European Urology · 2013 · 289 citations · Full text

Medicine, Genetics, Oncology +16

Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer

Bas W.G. van Rhijn, Tahlita C.M. Zuiverloon, André N. Vis et al. · European Urology · 2010 · 193 citations

Medicine, Oncology, Urology +14

Functional characterization of the lectin pathway of complement in human serum

Anja Roos, Lee H. Bouwman, Jeric R. Munoz et al. · Molecular Immunology · 2002 · 164 citations

Life Sciences, Biochemistry, Immunology +15

<i>Fibroblast Growth Factor Receptor 3</i> Mutation Analysis on Voided Urine for Surveillance of Patients with Low-Grade Non-Muscle–Invasive Bladder Cancer

Tahlita C.M. Zuiverloon, Madelon N.M. van der Aa, Theodorus van der Kwast et al. · Clinical Cancer Research · 2010 · 102 citations · Full text

Medicine, Oncology, Urology +13

A SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA gene

Carolyn D. Hurst, Tahlita C.M. Zuiverloon, Christian Hafner et al. · BMC Research Notes · 2009 · 98 citations · Full text

Medicine, Genetics, Oncology +17